AVTR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03

Precio $15.43

Capitalización Bursátil $10.52B

P/E (TTM) -18.4

BPA (TTM) $-0.84

Ingresos (TTM) $6.56B

ROE (TTM) -9.7%

Deuda/Capital (MRQ) 0.7

Rango 52S $7–$16

AVTR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04

rango

barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Acerca de Avantor, Inc. Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

History

The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.

That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.

The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”

Leer más Mostrar menos

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealthcare industriaLife Sciences Tools & Services empleados13 500 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06

Ingresos$6.55B

2017-12-31 → 2025-12-31

BPA$-0.78

2018-12-31 → 2025-12-31

Flujo de caja libre$495M

2019-12-31 → 2025-12-31

Margen neto-8.8%

2019-12-31 → 2025-12-31

Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
P/E (TTM)	-18.4promedio 5A ≈24.9	≈24.9	·	·
P/S	1.6promedio 5A ≈2.2	≈2.2	3.7	Infravalorado
P/B (P/C)	1.9promedio 5A ≈3.2	≈3.2	3.6	Infravalorado
EV / EBITDA	-57.3promedio 5A ≈10.3	≈10.3	·	·
Price / FCF (Precio / FCF)	21.3promedio 5A ≈21.7	≈21.7	·	·
Price / Cash Flow (Precio / Flujo de Caja)	16.9promedio 5A ≈18.2	≈18.2	25.2	Infravalorado
EV / Revenue (EV / Ingresos)	2.2promedio 5A ≈2.9	≈2.9	·	·
EV / FCF	28.5promedio 5A ≈28.9	≈28.9	·	·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
Margen Bruto (TTM)	31.8%promedio 5A ≈33.7%	≈33.7%	54.2%	Débil
Margen Operativo (TTM)	-4.6%promedio 5A ≈10.1%	≈10.1%	9.2%	Por debajo del promedio
EBITDA Margin (Margen EBITDA)	-3.8%promedio 5A ≈10.1%	≈10.1%	8.3%	Débil
Margen antes de impuestos (TTM)	-7.2%promedio 5A ≈6.7%	≈6.7%	5.9%	Por debajo del promedio
Margen de Beneficio Neto (TTM)	-8.8%promedio 5A ≈4.8%	≈4.8%	2.4%	En línea
ROA (TTM)	-4.7%promedio 5A ≈2.7%	≈2.7%	-0.14%	Débil
ROE (TTM)	-9.7%promedio 5A ≈7.6%	≈7.6%	-0.40%	Débil
ROIC	-3.1%promedio 5A ≈5.1%	≈5.1%	1.1%	Débil

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
Deuda / Patrimonio (MRQ)	0.7promedio 5A ≈1.1	≈1.1	0.7	En línea
Ratio corriente (MRQ)	1.8promedio 5A ≈1.6	≈1.6	3.0	Baja liquidez
Quick Ratio (Ratio Rápido)	1.0promedio 5A ≈0.9	≈0.9	1.6	Por debajo del promedio
Deuda a Largo Plazo / Patrimonio (MRQ)	0.7promedio 5A ≈1.0	≈1.0	0.7	En línea

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
Revenue YoY (Ingresos interanuales)	-3.4%promedio 5A ≈0.78%	≈0.78%	·	·
Revenue CAGR 3Y (Ingresos CAGR 3A)	-4.5%promedio 5A ≈-1.4%	≈-1.4%	·	·
Revenue CAGR 5Y (Ingresos CAGR 5A)	0.49%	·	·	·
EPS YoY (EPS interanual)	121.3%promedio 5A ≈232.8%	≈232.8%	·	·
Net Income YoY (Beneficio Neto interanual)	121.6%promedio 5A ≈119.8%	≈119.8%	·	·
EPS CAGR 3Y (CAGR BPA 3A)	7.0%	·	·	·
Net Income CAGR 3Y (CAGR Beneficio Neto 3A)	7.5%	·	·	·

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
EPS (Diluted) (BPA (Diluido))	$-0.78promedio 5A ≈$0.52	≈$0.52	·	·
Revenue / Share (Ingresos / Acción)	$9.63promedio 5A ≈$10.64	≈$10.64	·	·
Cash Flow / Share (Flujo de Caja / Acción)	$0.92promedio 5A ≈$1.25	≈$1.25	·	·
Cash / Share (Efectivo / Acción)	$0.54promedio 5A ≈$0.47	≈$0.47	·	·

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica	AVTR	promedio 5A	Mediana de Pares	Veredicto
Asset Turnover (Rotación de Activos)	0.5promedio 5A ≈0.6	≈0.6	0.5	En línea
Inventory Turnover (Rotación de Inventario)	5.7promedio 5A ≈5.7	≈5.7	2.5	De primer nivel
Receivables Turnover (Rotación de Cuentas por Cobrar)	6.2promedio 5A ≈6.2	≈6.2	5.7	De primer nivel
Revenue / Employee (Ingresos / Empleado)	≈$485.3K	·	·	·

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14

Sorpresa Media 0.49%

Próximo informe Oct 27, 2026

Período	Informe	EPS Actual	EPS est.	Sorpresa
30 de junio de 2026	Jul 30, 2026	$0.21	$0.19	8.6%
31 de marzo de 2026		$0.17	$0.16	6.2%
31 de diciembre de 2025		$0.22	$0.22	-0.36%
30 de septiembre de 2025		$0.22	$0.23	-4.0%
30 de junio de 2025		$0.24	$0.25	-5.1%
31 de marzo de 2025		$0.23	$0.24	-2.4%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15

Estado de resultados 16

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	$5.86B	$1.25B
Cost of Revenue	$4.41B	$4.50B	$4.60B	$4.91B	$4.88B	$4.31B	$4.12B	$4.04B	$815M
Gross Profit	$2.14B	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B	$1.92B	$1.82B	$433M
SG&A Expense	$1.60B	$1.64B	$1.51B	$1.47B	$1.53B	$1.37B	$1.37B	$1.41B	$450M
Operating Income	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	$414M	$-210M
Interest Expense	·	·	$285M	$266M	$217M	$308M	$440M	$524M	$201M
Interest Income	$42M	$75M	$65M	$16M	$2M	·	·	·	·
Other Non-op	$-21M	$-1M	$6M	$-800.0K	$11M	$10M	$2M	$-4M	$8M
Pretax Income	$-441M	$854M	$410M	$851M	$753M	$62M	$41M	$-114M	$-460M
Income Tax	$89M	$142M	$89M	$165M	$180M	$-54M	$3M	$-27M	$-315M
Net Income	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	$-87M	$-113M
EPS (Basic)	$-0.78	$1.05	$0.48	$1.02	$0.86	$0.09	$-0.84	$-2.69	·
EPS (Diluted)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	$-2.69	·
Shares (Basic)	680,600,000	679,600,000	675,600,000	650,900,000	590,500,000	576,300,000	401,200,000	132,700,000	·
Shares (Diluted)	680,600,000	681,900,000	678,400,000	679,400,000	599,600,000	583,400,000	401,200,000	132,700,000	·
EBITDA	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	·	·

Balance general 26

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$365M	$262M	$263M	$373M	$302M	$287M	$187M	$185M	·
Receivables	$1.07B	$1.03B	$1.15B	$1.22B	$1.22B	$1.11B	$989M	$931M	·
Inventory	$818M	$732M	$828M	$914M	$872M	$740M	$711M	$671M	·
Other Current Assets	$193M	$119M	$144M	$153M	$81M	$91M	$135M	$113M	·
Current Assets	$2.45B	$2.15B	$2.38B	$2.66B	$2.48B	$2.23B	$2.02B	$1.90B	·
PP&E (Net)	$767M	$708M	$738M	$727M	$706M	$550M	$557M	$599M	·
PP&E (Gross)	$1.51B	$1.34B	$1.35B	$1.25B	$1.15B	$938M	$865M	$824M	·
Accum. Depreciation	$745M	$630M	$617M	$518M	$445M	$388M	$308M	$226M	·
Goodwill	$4.99B	$5.54B	$5.72B	$5.65B	$5.34B	$2.86B	$2.77B	$2.78B	$2.85B
Intangibles	$3.10B	$3.27B	$3.68B	$4.04B	$5.05B	$3.96B	$4.13B	$4.47B	·
Other Non-current Assets	$396M	$360M	$358M	$294M	$233M	$217M	$205M	$63M	·
Total Assets	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Accounts Payable	$742M	$663M	$626M	$758M	$755M	$679M	$560M	$557M	·
Current Liabilities	$1.38B	$2.01B	$1.48B	$1.66B	$1.45B	$1.24B	$1.07B	$1.10B	·
Capital Leases	$152M	$143M	$88M	$87M	$79M	·	$107M	·	·
Deferred Tax	$557M	$557M	$613M	$731M	$913M	$724M	$785M	$908M	·
Other Non-current Liabilities	$378M	$358M	$350M	$295M	$358M	$398M	$428M	$318M	·
Total Liabilities	$6.23B	$6.16B	$7.72B	$8.61B	$9.70B	$7.23B	$7.31B	$9.10B	·
Long-term Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	$6.92B	·
Total Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	·	·
Retained Earnings	$1.67B	$2.20B	$1.49B	$1.17B	$484M	$-89M	$-204M	$-238M	·
Treasury Stock	$76M	$0	·	·	·	·	·	·	·
AOCI	$-17M	$-184M	$-69M	$-100M	$-43M	$22M	$-86M	$-66M	$26M
Stockholders' Equity	$5.57B	$5.96B	$5.25B	$4.86B	$4.20B	$2.67B	$2.46B	$-3.05B	$-2.62B
Liabilities + Equity	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Shares Outstanding	682,000,000	680,800,000	676,600,000	674,300,000	609,700,000	580,100,000	572,800,000	132,800,000	·

Flujo de Efectivo 18

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$410M	$406M	$402M	$406M	$379M	$395M	$399M	$405M	$99M
Stock-based Comp	$46M	$47M	$40M	$46M	$51M	$44M	$68M	$18M	$48M
Deferred Tax	$8M	$-47M	$-172M	$-69M	$-18M	$-88M	$-107M	$-104M	$-431M
Amort. of Intangibles	$301M	$300M	$308M	$318M	$291M	$308M	$312M	$321M	$65M
Restructuring	$30M	$83M	$26M	$4M	$5M	$12M	$24M	$81M	$30M
Operating Cash Flow	$624M	$841M	$870M	$844M	$954M	$930M	$354M	$200M	$-168M
CapEx	$129M	$149M	$146M	$133M	$111M	$62M	$52M	$38M	$25M
Investing Cash Flow	$-130M	$439M	$-144M	$-110M	$-4.12B	$-59M	$-42M	$-23M	$-6.68B
Debt Issued	$1.11B	$0	$0	$327M	$2.83B	$3.94B	$1M	$36M	$9.25B
Net Debt Issued	$-319M	$-1.34B	$-846M	$-620M	$2.30B	$-423M	$-1.88B	·	·
Stock Issued	·	·	$0	$0	$967M	$0	$4.24B	·	·
Stock Repurchased	$75M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-75M	·	$0	$0	$967M	·	·	·	·
Financing Cash Flow	$-409M	$-1.28B	$-844M	$-649M	$3.22B	$-783M	$-308M	$-170M	$6.96B
Net Change in Cash	$104M	$-23M	$-109M	$70M	$38M	$100M	$2M	$-800.0K	$122M
Taxes Paid	$145M	$248M	$224M	$257M	$145M	$43M	$112M	$66M	$32M
Free Cash Flow	$495M	$692M	$724M	$710M	$842M	$868M	$302M	·	·
Levered FCF	·	·	$501M	$496M	$677M	$292M	$-107M	·	·

Rentabilidad 8

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	32.6%	33.6%	33.9%	34.6%	33.9%	32.5%	31.8%	·	·
Operating Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
Net Margin	-8.1%	10.5%	4.6%	9.1%	7.8%	1.8%	0.63%	·	·
Pretax Margin	-6.7%	12.6%	5.9%	11.3%	10.2%	0.97%	0.67%	·	·
EBITDA Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
ROA	-4.4%	5.7%	2.4%	5.0%	4.8%	1.2%	0.38%	·	·
ROE	-8.9%	12.4%	6.2%	14.5%	13.8%	4.5%	1.6%	·	·
ROIC	-3.1%	9.0%	5.1%	8.2%	6.6%	17.5%	6.8%	·	·

Liquidez y Solvencia 5

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	1.8	1.1	1.6	1.6	1.7	1.8	1.9	·	·
Quick Ratio	1.0	0.6	1.0	1.0	1.1	1.1	1.1	·	·
Debt / Equity	0.7	0.7	1.1	1.3	1.7	1.8	2.1	·	·
LT Debt / Equity	0.7	0.5	1.0	1.2	1.7	1.8	2.0	·	·
Interest Coverage	·	·	2.4	4.3	4.5	2.3	1.3	·	·

Eficiencia 3

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	·	·
Inventory Turnover	5.7	5.8	5.3	5.5	6.1	5.9	6.0	·	·
Receivables Turnover	6.2	6.2	5.9	6.2	6.3	6.1	6.3	·	·

Por Acción 5

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$8.16	$8.75	$7.76	$7.20	$6.88	$4.61	$4.30	·	·
Revenue / Share	$9.63	$9.95	$10.27	$11.06	$12.32	$10.96	·	·	·
Cash Flow / Share	$0.92	$1.23	$1.28	$1.24	$1.59	$1.59	·	·	·
Cash / Share	$0.54	$0.38	$0.39	$0.55	$0.49	$0.49	$0.33	·	·
EPS (TTM)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	·	·

Tasas de Crecimiento 7

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-3.4%	-2.6%	-7.3%	1.7%	15.5%	·	·	·	·
Revenue CAGR 3Y	-4.5%	-2.8%	2.9%	·	·	·	·	·	·
Revenue CAGR 5Y	0.49%	·	·	·	·	·	·	·	·
EPS YoY	·	121.3%	-53.5%	18.8%	844.4%	·	·	·	·
EPS CAGR 3Y	·	7.0%	73.5%	·	·	·	·	·	·
Net Income YoY	·	121.6%	-53.2%	19.9%	391.1%	·	·	·	·
Net Income CAGR 3Y	·	7.5%	40.2%	·	·	·	·	·	·

Valoración (TTM) 13

Métrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	·	·
Net Income TTM	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	·	·
Market Cap	$7.82B	$14.34B	$15.45B	$14.22B	$25.69B	$16.33B	$10.40B	·	·
Enterprise Value	$11.40B	$18.14B	$20.72B	$20.14B	$32.41B	$20.94B	$15.33B	·	·
P/E	-14.7	20.3	48.6	20.9	49.6	312.8	-21.6	·	·
P/S	1.2	2.1	2.2	1.9	3.5	2.6	1.7	·	·
P/B	1.4	2.4	2.9	2.9	6.1	6.1	4.2	·	·
P / Cash Flow	12.5	17.1	17.8	16.9	26.9	17.6	29.4	·	·
P / FCF	15.8	20.7	21.3	20.0	30.5	18.8	34.4	·	·
EV / EBITDA	-46.3	16.7	29.8	17.8	33.3	29.6	27.8	·	·
EV / FCF	23.0	26.2	28.6	28.4	38.5	24.1	50.7	·	·
EV / Revenue	1.7	2.7	3.0	2.7	4.4	3.3	2.5	·	·
Earnings Yield	-6.8%	4.9%	2.1%	4.8%	2.0%	0.32%	-4.6%	·	·

Estado de resultados 16

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1.69B	$1.58B	$1.66B	$1.62B	$1.68B	$1.58B	$1.69B	$1.71B	$1.70B	$1.68B	$1.72B	$1.72B	$1.74B	$1.78B	$1.79B	$1.86B
Cost of Revenue	$1.16B	$1.08B	$1.14B	$1.10B	$1.13B	$1.05B	$1.12B	$1.15B	$1.12B	$1.11B	$1.15B	$1.14B	$1.15B	$1.16B	$1.18B	$1.21B
Gross Profit	$537M	$501M	$524M	$526M	$554M	$535M	$563M	$564M	$582M	$570M	$570M	$579M	$590M	$625M	$614M	$651M
SG&A Expense	$415M	$401M	$392M	$390M	$425M	$388M	$371M	$440M	$406M	$424M	$387M	$368M	$358M	$394M	$363M	$375M
Operating Income	$122M	$100M	$126M	$-649M	$129M	$147M	$638M	$125M	$176M	$146M	$183M	$210M	$72M	$231M	$252M	$276M
Interest Expense	$39M	$43M	·	$44M	$43M	$42M	·	$49M	$61M	$64M	·	$72M	$73M	$74M	·	$67M
Interest Income	$10M	$10M	$11M	$12M	$11M	$8M	$12M	$27M	$18M	$18M	$18M	$17M	$16M	$14M	·	·
Other Non-op	$-600.0K	$-500.0K	$-1M	$4M	$-4M	$-20M	$-5M	$700.0K	$2M	$1M	$2M	$700.0K	$2M	$600.0K	$-6M	$3M
Pretax Income	$81M	$56M	$81M	$-690M	$82M	$86M	$584M	$74M	$115M	$81M	$120M	$136M	$-1M	$156M	$175M	$208M
Income Tax	$43M	$12M	$28M	$22M	$17M	$21M	$84M	$17M	$22M	$20M	$21M	$28M	$6M	$34M	$33M	$41M
Net Income	$38M	$43M	$52M	$-712M	$65M	$64M	$500M	$58M	$93M	$60M	$98M	$108M	$-7M	$122M	$142M	$167M
EPS (Basic)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.74	$0.08	$0.14	$0.09	$0.15	$0.16	$-0.01	$0.18	$0.20	$0.25
EPS (Diluted)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.73	$0.08	$0.14	$0.09	$0.14	$0.16	$-0.01	$0.18	$0.20	$0.25
Shares (Basic)	676,200,000	675,700,000	·	681,700,000	681,500,000	681,100,000	·	680,300,000	679,400,000	678,100,000	·	676,000,000	675,300,000	674,700,000	·	674,100,000
Shares (Diluted)	677,200,000	676,800,000	·	681,700,000	681,800,000	682,400,000	·	683,000,000	682,600,000	681,400,000	·	678,500,000	675,300,000	678,100,000	·	679,300,000
EBITDA	$122M	$100M	·	$-649M	$129M	$147M	·	$125M	$176M	$146M	·	$210M	$72M	$231M	·	$276M

Balance general 26

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$307M	$279M	$365M	$252M	$449M	$316M	$262M	$285M	$273M	$235M	·	$237M	$236M	$295M	·	$266M
Receivables	$1.14B	$1.10B	$1.07B	$1.08B	$1.15B	$1.10B	$1.03B	$1.09B	$1.13B	$1.13B	·	$1.15B	$1.22B	$1.28B	·	$1.23B
Inventory	$829M	$810M	$818M	$796M	$780M	$750M	$732M	$780M	$796M	$811M	·	$850M	$890M	$904M	·	$905M
Other Current Assets	$188M	$210M	$193M	$132M	$136M	$120M	$119M	$136M	$132M	$146M	·	$147M	$156M	$152M	·	$158M
Current Assets	$2.46B	$2.40B	$2.45B	$2.26B	$2.51B	$2.28B	$2.15B	$2.50B	$2.33B	$2.32B	·	$2.38B	$2.50B	$2.63B	·	$2.56B
PP&E (Net)	$772M	$766M	$767M	$762M	$759M	$736M	$708M	$723M	$754M	$740M	·	$698M	$698M	$736M	·	$698M
PP&E (Gross)	·	·	$1.51B	·	·	·	$1.34B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$787M	$766M	$745M	$724M	$700M	$663M	$630M	$621M	$657M	$635M	·	$580M	$565M	$541M	·	$489M
Goodwill	$4.94B	$4.95B	$4.99B	$4.98B	$5.76B	$5.61B	$5.54B	$5.67B	$5.66B	$5.67B	$5.72B	$5.64B	$5.69B	$5.68B	$5.65B	$5.51B
Intangibles	$2.92B	$3.01B	$3.10B	$3.17B	$3.26B	$3.24B	$3.27B	$3.43B	$3.49B	$3.57B	·	$3.70B	$3.80B	$3.98B	·	$4.01B
Other Non-current Assets	$412M	$442M	$396M	$406M	$391M	$368M	$360M	$420M	$368M	$368M	·	$289M	$277M	$272M	·	$245M
Total Assets	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Accounts Payable	$743M	$736M	$742M	$692M	$709M	$680M	$663M	$674M	$657M	$573M	·	$656M	$687M	$766M	·	$769M
Current Liabilities	$1.38B	$1.37B	$1.38B	$1.52B	$2.58B	$2.03B	$2.01B	$1.63B	$1.46B	$1.44B	·	$1.49B	$1.55B	$1.67B	·	$1.55B
Capital Leases	·	·	$152M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Deferred Tax	$540M	$550M	$557M	$548M	$536M	$550M	$557M	$547M	$575M	$601M	·	$649M	$663M	$696M	·	$728M
Other Non-current Liabilities	$383M	$377M	$378M	$403M	$391M	$365M	$358M	$419M	$362M	$361M	·	$271M	$269M	$300M	·	$334M
Total Liabilities	$5.97B	$6.07B	$6.23B	$6.11B	$6.49B	$6.23B	$6.16B	$7.29B	$7.26B	$7.43B	·	$7.70B	$8.05B	$8.40B	·	$8.52B
Long-term Debt	$3.70B	$3.82B	$3.95B	$3.86B	$4.24B	$4.11B	$4.06B	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Total Debt	$3.70B	$3.82B	·	$3.86B	$4.24B	$4.11B	·	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Retained Earnings	$1.75B	$1.72B	$1.67B	$1.62B	$2.33B	$2.27B	$2.20B	$1.70B	$1.64B	$1.55B	·	$1.39B	$1.28B	$1.29B	·	$1.03B
Treasury Stock	$76M	$76M	$76M	·	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-55M	$-44M	$-17M	$-24M	$-10M	$-118M	$-184M	$-74M	$-107M	$-97M	·	$-111M	$-72M	$-90M	$-100M	$-212M
Stockholders' Equity	$5.63B	$5.59B	$5.57B	$5.57B	$6.29B	$6.10B	$5.96B	$5.55B	$5.43B	$5.34B	$5.25B	$5.10B	$5.01B	$4.99B	$4.86B	$4.59B
Liabilities + Equity	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Shares Outstanding	·	682,900,000	682,000,000	681,900,000	681,600,000	681,500,000	680,800,000	680,600,000	679,600,000	679,200,000	·	676,300,000	675,700,000	675,100,000	·	674,200,000

Flujo de Efectivo 14

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$106M	$105M	$103M	$104M	$103M	$100M	$101M	$102M	$103M	$100M	$101M	$98M	$103M	$101M	$101M	$101M
Stock-based Comp	$15M	$9M	$11M	$7M	$16M	$12M	$11M	$12M	$11M	$13M	$9M	$10M	$9M	$13M	$10M	$12M
Deferred Tax	$16M	$-10M	$50M	$-12M	$-18M	$-12M	$28M	$-23M	$-35M	$-18M	$-78M	$-29M	$-38M	$-26M	$-7M	$-22M
Restructuring	·	·	$2M	$2M	·	·	$500.0K	$49M	·	·	$8M	$6M	$7M	$5M	$-200.0K	$1M
Operating Cash Flow	$178M	$59M	$153M	$207M	$154M	$109M	$173M	$245M	$281M	$142M	$252M	$231M	$168M	$220M	$206M	$258M
CapEx	$38M	$34M	$36M	$36M	$30M	$28M	$28M	$41M	$46M	$35M	$51M	$38M	$30M	$28M	$34M	$39M
Investing Cash Flow	$-37M	$-33M	$-40M	$-33M	$-29M	$-29M	$558M	$-40M	$-45M	$-34M	$-50M	$-37M	$-29M	$-27M	$-33M	$4M
Debt Issued	·	·	$1.04B	$68M	$0	$0	$0	$-12M	$-29M	$41M	$0	$0	$0	$0	$82M	$35M
Net Debt Issued	·	$-105M	·	·	·	$-31M	·	·	·	$-169M	·	·	·	$-270M	·	·
Financing Cash Flow	$-112M	$-107M	$700.0K	$-370M	$-7M	$-34M	$-755M	$-199M	$-197M	$-130M	$-184M	$-188M	$-196M	$-275M	$-82M	$-219M
Net Change in Cash	$28M	$-86M	$114M	$-198M	$134M	$54M	$-46M	$14M	$38M	$-28M	$27M	$-100.0K	$-58M	$-78M	$109M	$27M
Taxes Paid	$30M	$10M	$29M	$22M	$77M	$17M	$120M	$42M	$69M	$17M	$29M	$69M	$113M	$14M	$75M	$51M
Free Cash Flow	·	$25M	·	·	·	$81M	·	·	·	$107M	·	·	·	$192M	·	·
Levered FCF	·	$-8M	·	·	·	$50M	·	·	·	$59M	·	·	·	$134M	·	·

Rentabilidad 8

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	31.7%	31.7%	·	32.4%	32.9%	33.8%	·	32.9%	34.2%	34.0%	·	33.6%	33.8%	35.1%	·	35.0%
Operating Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
Net Margin	2.2%	2.7%	·	-43.8%	3.8%	4.1%	·	3.4%	5.5%	3.6%	·	6.3%	-0.42%	6.8%	·	9.0%
Pretax Margin	4.8%	3.5%	·	-42.5%	4.9%	5.4%	·	4.3%	6.7%	4.8%	·	7.9%	-0.07%	8.8%	·	11.2%
EBITDA Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
ROA	0.31%	0.36%	·	-5.8%	0.51%	0.51%	·	0.45%	0.72%	0.46%	·	0.84%	-0.06%	0.89%	·	1.3%
ROE	0.64%	0.74%	·	-12.8%	1.1%	1.1%	·	1.1%	1.8%	1.2%	·	2.2%	-0.15%	2.6%	·	3.8%
ROIC	0.61%	0.83%	·	-7.1%	0.97%	1.1%	·	0.92%	1.4%	1.0%	·	1.6%	3.7%	1.6%	·	2.1%

Liquidez y Solvencia 5

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	1.5	1.0	1.1	·	1.5	1.6	1.6	·	1.6	1.6	1.6	·	1.6
Quick Ratio	1.0	1.0	·	0.9	0.6	0.7	·	0.8	1.0	0.9	·	0.9	0.9	0.9	·	1.0
Debt / Equity	0.7	0.7	·	0.7	0.7	0.7	·	0.9	0.9	1.0	·	1.1	1.2	1.2	·	1.3
LT Debt / Equity	0.7	0.7	·	0.7	0.5	0.5	·	0.8	0.9	0.9	·	1.0	1.1	1.1	·	1.3
Interest Coverage	3.1	2.3	·	-14.7	3.0	3.5	·	2.6	2.9	2.3	·	2.9	1.0	3.1	·	4.1

Eficiencia 3

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	1.4	1.4	·	1.4	1.4	1.3	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.4
Receivables Turnover	1.5	1.4	·	1.5	1.5	1.4	·	1.5	1.5	1.4	·	1.4	1.4	1.4	·	1.5

Por Acción 5

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$8.18	·	$8.17	$9.22	$8.95	·	$8.16	$8.00	$7.86	·	$7.54	$7.42	$7.40	·	$6.81
Revenue / Share	$2.50	$2.34	·	$2.38	$2.47	$2.32	·	$2.51	$2.49	$2.47	·	$2.54	$2.58	$2.63	·	$2.73
Cash Flow / Share	·	$0.09	·	·	·	$0.16	·	·	·	$0.21	·	·	·	$0.32	·	·
Cash / Share	·	$0.41	·	$0.37	$0.66	$0.46	·	$0.42	$0.40	$0.35	·	$0.35	$0.35	$0.44	·	$0.39
EPS (TTM)	$-0.84	$-0.81	·	$-0.13	$0.99	$1.04	·	$0.45	$0.53	$0.38	·	$0.53	$0.62	$0.91	·	$0.93

Valoración (TTM) 10

Métrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$6.56B	$6.55B	·	$6.58B	$6.67B	$6.69B	·	$6.82B	$6.83B	$6.87B	·	$7.04B	$7.18B	$7.34B	·	$7.62B
Net Income TTM	$-578M	$-551M	·	$-82M	$687M	$716M	·	$310M	$360M	$260M	·	$364M	$423M	$618M	·	$639M
Market Cap	·	$5.35B	·	$8.51B	$9.17B	$11.05B	·	$17.61B	$14.41B	$17.37B	·	$14.26B	$13.88B	$14.27B	·	$13.21B
Enterprise Value	·	$8.89B	·	$12.12B	$12.97B	$14.84B	·	$22.24B	$19.25B	$22.46B	·	$19.65B	$19.53B	$20.04B	·	$19.14B
P/E	-11.8	-9.7	·	-96.0	13.6	15.6	·	57.5	40.0	67.3	·	39.8	33.1	23.2	·	21.1
P/S	·	0.8	·	1.3	1.4	1.7	·	2.6	2.1	2.5	·	2.0	1.9	1.9	·	1.7
P/B	·	1.0	·	1.5	1.5	1.8	·	3.2	2.7	3.3	·	2.8	2.8	2.9	·	2.9
P / Cash Flow	·	91.2	·	·	·	101.1	·	·	·	122.6	·	·	·	65.0	·	·
EV / Revenue	·	1.4	·	1.8	1.9	2.2	·	3.3	2.8	3.3	·	2.8	2.7	2.7	·	2.5
Earnings Yield	-8.5%	-10.3%	·	-1.0%	7.4%	6.4%	·	1.7%	2.5%	1.5%	·	2.5%	3.0%	4.3%	·	4.7%

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ingresos	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B
Margen Bruto %	32.6%	33.6%	33.9%	34.6%	33.9%
Margen Operativo %	-3.8%	16.0%	10.0%	15.0%	13.2%
Beneficio neto	$-530M	$712M	$321M	$686M	$573M
EPS Diluido	$-0.78	$1.04	$0.47	$1.01	$0.85

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Deuda / Patrimonio	0.7	0.7	1.1	1.3	1.7
Ratio corriente	1.8	1.1	1.6	1.6	1.7
Ratio Rápido	1.0	0.6	1.0	1.0	1.1

Métrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flujo de caja libre	$495M	$692M	$724M	$710M	$842M

Propietarios institucionales (13F) 493 declarantes · $7.6B total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 493

Valor en tenencia $7.6B

Nuevas posiciones 97

Posiciones cerradas 60

Actividad institucional — Q2 2026 vs trimestre anterior

Nuevas posiciones	Posiciones cerradas	Aumentado	Disminuido	Cambio neto de acciones
97 (-7 vs trimestre anterior)	60 (-11 vs trimestre anterior)	192 (+31 vs trimestre anterior)	113 (-15 vs trimestre anterior)	+24.9M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución	Valor	Acciones	% de 13F rastreadas	Tipo
Dodge & Cox	$1 188 207 643	120 020 974	15,59%	Acciones
VANGUARD GROUP INC	$743 810 028	64 904 889	9,76%	Acciones
BlackRock, Inc.	$695 784 194	70 281 231	9,13%	Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC	$310 298 175	31 343 250	4,07%	Acciones
VANGUARD CAPITAL MANAGEMENT LLC	$304 948 067	30 802 835	4,00%	Acciones
GREENHAVEN ASSOCIATES INC	$243 909 369	24 637 310	3,20%	Acciones
STATE STREET CORP	$213 572 443	21 572 974	2,80%	Acciones
DIMENSIONAL FUND ADVISORS LP	$202 086 268	20 412 181	2,65%	Acciones
Engine Capital Management, LP	$196 622 217	19 860 830	2,58%	Acciones
BARROW HANLEY MEWHINNEY & STRAUSS LLC	$195 386 083	19 735 968	2,56%	Acciones
New Mountain Capital, L.L.C.	$138 600 000	14 000 000	1,82%	Acciones
Invesco Ltd.	$137 465 065	13 885 360	1,80%	Acciones
GEODE CAPITAL MANAGEMENT, LLC	$130 519 321	13 180 567	1,71%	Acciones
MARSHALL WACE, LLP	$129 988 565	13 130 158	1,71%	Acciones
AQR CAPITAL MANAGEMENT LLC	$115 112 902	11 627 566	1,51%	Acciones
BANK OF AMERICA CORP /DE/	$108 794 506	10 989 344	1,43%	Acciones
EARNEST PARTNERS LLC	$106 410 397	10 748 525	1,40%	Acciones
LONDON CO OF VIRGINIA	$103 811 008	10 485 960	1,36%	Acciones
FULLER & THALER ASSET MANAGEMENT, INC.	$101 537 816	10 256 345	1,33%	Acciones
D. E. Shaw & Co., Inc.	$94 758 077	9 571 523	1,24%	Acciones
First Pacific Advisors, LP	$81 088 326	8 190 740	1,06%	Acciones
SEI INVESTMENTS CO	$78 677 367	7 947 198	1,03%	Acciones
FMR LLC	$77 670 074	7 845 462	1,02%	Acciones
GENDELL JEFFREY L	$75 311 973	7 607 270	0,99%	Acciones
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$73 188 967	7 392 825	0,96%	Acciones
Clarkston Capital Partners, LLC	$67 214 209	6 789 314	0,88%	Acciones
MORGAN STANLEY	$66 905 804	6 758 161	0,88%	Acciones
GOLDMAN SACHS GROUP INC	$61 422 976	6 204 341	0,81%	Acciones
NORGES BANK	$60 307 949	6 091 712	0,79%	Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$57 627 950	5 821 005	0,76%	Acciones
NORTHERN TRUST CORP	$56 753 512	5 732 678	0,74%	Acciones
Freestone Grove Partners LP	$56 577 352	5 714 884	0,74%	Acciones
UBS Group AG	$56 155 742	5 672 297	0,74%	Acciones
AMERIPRISE FINANCIAL INC	$54 696 928	5 524 942	0,72%	Acciones
YACKTMAN ASSET MANAGEMENT LP	$47 223 000	4 770 000	0,62%	Acciones
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	$46 782 232	4 725 478	0,61%	Acciones
Brickwood Asset Management LLP	$45 515 438	4 597 519	0,60%	Acciones
VANGUARD FIDUCIARY TRUST CO	$42 790 226	4 322 245	0,56%	Acciones
JONES FINANCIAL COMPANIES LLLP	$42 363 659	4 120 981	0,56%	Acciones
Bank of New York Mellon Corp	$40 800 098	4 121 222	0,54%	Acciones
ROYCE & ASSOCIATES LP	$36 393 232	3 676 084	0,48%	Acciones
FRONTIER CAPITAL MANAGEMENT CO LLC	$34 719 001	3 506 970	0,46%	Acciones
PRIVATE MANAGEMENT GROUP INC	$30 662 617	3 097 234	0,40%	Acciones
Voss Capital, LP	$26 235 000	2 650 000	0,34%	Acciones
Prescott General Partners LLC	$25 740 000	2 600 000	0,34%	Acciones
Gotham Asset Management, LLC	$24 912 796	2 516 444	0,33%	Acciones
Quantinno Capital Management LP	$24 177 175	2 442 138	0,32%	Acciones
KINNEY ASSET MANAGEMENT, LLC	$23 025 600	1 845 000	0,30%	Acciones
Loews Corp	$21 780 000	2 200 000	0,29%	Acciones
Western Standard LLC	$20 888 842	2 109 984	0,27%	Acciones

Mostrar todos los 493 propietarios institucionales →

Activistas y propietarios del %+ 5 1 tenencia

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante	Presentado	Participación	Estado	Propósito	Presentación
The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 presentaciones	7 de mayo de 2021	·	Presentación inicial	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 47 insiders · 29 directivos · 20 consejeros

19

Insider	Rol	Última actividad	Acciones en propiedad	Compras 12m	Neto 12m
Emmanuel Ligner	President and CEO	18 de agosto de 2026 F	737 334	1	$993 125
Michael Stubblefield	President & CEO	21 de mayo de 2025 G	545 500	0	$0
Todd W. Garner	EVP and CFO	21 de septiembre de 2026 A	49 688	0	$0
Brent R. Jones	EVP, Chief Financial Officer	23 de febrero de 2026 F	419 782	0	$0
Thomas A Szlosek	EVP & CFO	17 de mayo de 2023 F	77 489	0	$0
Corey Walker	President, VWR Dist. & Servs.	21 de junio de 2026 F	384 535	0	$0
Mary Blenn	EVP, Chief Operating Officer	19 de febrero de 2026 A	253 384	0	$0
Bjorn Hofman	EVP and COO	21 de mayo de 2019 A	157 143	0	$0
Brittany Hankamer	EVP, Chief HR Officer	14 de agosto de 2026 F	248 864	0	$0
Steven W Eck	SVP & Chief Accounting Officer	31 de julio de 2026 F	129 593	0	$0
Claudius Sokenu	EVP, Chief Legal & Compliance	24 de julio de 2026 F	251 228	0	$0
Ludovic Brellier	EVP, Bioscience & Medtech	1 de mayo de 2026 A	146 566	0	$0
Benoit Gourdier	EVP, Bioscience & Medtech	23 de febrero de 2026 F	362 859	0	$0
Christophe Couturier	EVP, AMEA	8 de agosto de 2025 A	211 271	0	$0
James Bramwell	EVP Sales, Customer Excellence	27 de febrero de 2025 S	86 605	0	$0
Kitty Sahin	EVP, Strategy&Corp Development	18 de julio de 2024 F	42 274	0	$0
Randy Lee Stone	EVP, Laboratory Solutions	16 de abril de 2024 F	68 105	0	$0
Sheri Lewis	EVP, Global Ops & Supply Chain	31 de diciembre de 2023 F	70 692	0	$0
Frederic Vanderhaegen	EVP, Americas and Europe	25 de agosto de 2023 S	160 735	0	$0
Justin Miller	EVP & General Counsel	17 de mayo de 2023 F	93 336	0	$0
Gerard Brophy	EVP, Biopharma Production	17 de mayo de 2023 F	89 032	0	$0
Meghan Henson	EVP, Chief HR Officer	24 de febrero de 2023 A	40 184	0	$0
Michael Wondrasch	EVP & CIO	20 de febrero de 2023 F	96 072	0	$0
Mark Christopher Murray	EVP, Biomaterials & AT	13 de enero de 2022 F	18 680	0	$0
Devashish Ohri	EVP, IMEA	27 de mayo de 2021 M	139 095	0	$0
Sven Henrichwark	EVP, APAC Region	25 de febrero de 2021 A	19 802	0	$0
Eric Mcallister	EVP, CHRO	17 de mayo de 2020 F	197 899	0	$0
Tanya Foxe	EVP, Operations & Supply Chain	21 de febrero de 2020 A	39 458	0	$0
Ashish Kulkarni	EVP and Chief Technology Officer	21 de mayo de 2019 A	128 571	0	$0
Gregory T Lucier	Consejero	8 de mayo de 2026 P	60 000	2	$541 200
Simon Dingemans	Consejero	7 de mayo de 2026 A	31 495	1	$203 500
Louise Makin	Consejero	7 de mayo de 2026 A	47 140	0	$0
Mala Murthy	Consejero	7 de mayo de 2026 A	69 479	0	$0
Michael Severino	Consejero	7 de mayo de 2026 A	85 821	0	$0
Joseph R Massaro	Consejero	7 de mayo de 2026 A	77 408	0	$0
Gregory L Summe	Consejero	7 de mayo de 2026 A	83 381	2	$2 065 000
Sanjeev K Mehra	Consejero	7 de mayo de 2026 A	33 376	2	$4 882 750
John Carethers	Consejero	8 de mayo de 2025 A	45 858	0	$0
Lan Kang	Consejero	8 de mayo de 2025 A	52 315	0	$0
Juan Andres	Consejero	8 de mayo de 2025 A	65 480	0	$0
Jonathan M Peacock	Consejero	8 de mayo de 2025 A	219 815	0	$0
Christi Shaw	Consejero	11 de mayo de 2023 A	36 271	0	$0
Matthew S. Holt	Consejero	12 de mayo de 2022 A	7 908	0	$0
Rajiv Gupta	Consejero	1 de abril de 2022 A	780 562	0	$0
Jo Natauri	Consejero	12 de julio de 2021 P	557 656	0	$0
Rakesh Sachdev	Consejero	25 de febrero de 2021 A	32 841	0	$0
Thomas Connolly	Consejero	18 de junio de 2020 S	72 620 082	0	$0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 56 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo	Ponderación	Unidades	A fecha de	Fuente
LSEQ · Harbor ETF Trust	2,52%	27 960 NS	31 de julio de 2026	N-PORT
EPSB · Harbor ETF Trust	1,77%	6 133 NS	31 de julio de 2026	N-PORT
BSJS · Invesco Exchange-Traded Self-Indexe…	1,51%	11 851 000	5 de octubre de 2026	Diario
DFSV · Dimensional ETF Trust	0,52%	3 118 943 NS	31 de julio de 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0,40%	25 471 NS	31 de julio de 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0,39%	586 296 SH	19 de agosto de 2026	Diario
QVMM · Invesco Exchange-Traded Fund Trust …	0,33%	88 982 SH	5 de octubre de 2026	Diario
RWK · Invesco Exchange-Traded Fund Trust …	0,28%	230 747 SH	5 de octubre de 2026	Diario
VFVA · VANGUARD WELLINGTON FUND	0,27%	233 604 SH	19 de agosto de 2026	Diario
PTMC · Pacer Funds Trust	0,27%	75 616 NS	31 de julio de 2026	N-PORT
NUSC · Nushares ETF Trust	0,20%	188 520 NS	31 de julio de 2026	N-PORT
MIDU · Direxion Shares ETF Trust	0,20%	10 027 NS	31 de julio de 2026	N-PORT
ESML · iShares Trust	0,20%	376 218 SH	11 de septiembre de 2026	Diario
BBMC · J.P. Morgan Exchange-Traded Fund Tr…	0,19%	286 321 NS	31 de julio de 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0,19%	1 104 592 SH	19 de agosto de 2026	Diario
DFAT · Dimensional ETF Trust	0,17%	1 765 932 NS	31 de julio de 2026	N-PORT
DFAS · Dimensional ETF Trust	0,17%	1 854 609 NS	31 de julio de 2026	N-PORT
IYH · iShares Trust	0,16%	386 410 SH	11 de septiembre de 2026	Diario
VBR · VANGUARD INDEX FUNDS	0,14%	9 920 672 SH	19 de agosto de 2026	Diario
SMMD · iShares Trust	0,14%	351 599 SH	11 de septiembre de 2026	Diario
FHLC · FIDELITY COVINGTON TRUST	0,13%	313 238 NS	31 de julio de 2026	N-PORT
REVS · Columbia ETF Trust I	0,12%	28 653 NS	31 de julio de 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,10%	1 983 361 SH	19 de agosto de 2026	Diario
EQAL · Invesco Exchange-Traded Fund Trust …	0,10%	50 803 SH	5 de octubre de 2026	Diario
IWS · iShares Trust	0,10%	978 878 SH	11 de septiembre de 2026	Diario
WSML · iShares Trust	0,09%	41 659 SH	11 de septiembre de 2026	Diario
VXF · VANGUARD INDEX FUNDS	0,08%	7 835 858 SH	19 de agosto de 2026	Diario
VB · VANGUARD INDEX FUNDS	0,08%	15 636 784 SH	19 de agosto de 2026	Diario
TILT · FlexShares Trust	0,08%	121 976 NS	31 de julio de 2026	N-PORT
RECS · Columbia ETF Trust I	0,08%	325 274 NS	31 de julio de 2026	N-PORT
IWR · iShares Trust	0,07%	2 700 866 SH	11 de septiembre de 2026	Diario
IUS · Invesco Exchange-Traded Self-Indexe…	0,06%	37 709 SH	5 de octubre de 2026	Diario
PRF · Invesco Exchange-Traded Fund Trust	0,04%	251 969 SH	5 de octubre de 2026	Diario
IUSV · iShares Trust	0,03%	593 664 SH	11 de septiembre de 2026	Diario
DXUV · Dimensional ETF Trust	0,03%	11 452 NS	31 de julio de 2026	N-PORT
IWD · iShares Trust	0,03%	1 462 438 SH	11 de septiembre de 2026	Diario
VONV · VANGUARD SCOTTSDALE FUNDS	0,02%	397 791 SH	19 de agosto de 2026	Diario
IYY · iShares Trust	0,01%	29 349 SH	11 de septiembre de 2026	Diario
IWB · iShares Trust	0,01%	457 613 SH	11 de septiembre de 2026	Diario
ITOT · iShares Trust	0,01%	885 606 SH	11 de septiembre de 2026	Diario
IWV · iShares Trust	0,01%	183 968 SH	11 de septiembre de 2026	Diario
VTI · VANGUARD INDEX FUNDS	0,01%	21 681 946 SH	19 de agosto de 2026	Diario
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,01%	534 809 SH	19 de agosto de 2026	Diario
VONE · VANGUARD SCOTTSDALE FUNDS	0,01%	109 164 SH	19 de agosto de 2026	Diario
VTHR · VANGUARD SCOTTSDALE FUNDS	0,01%	55 632 SH	19 de agosto de 2026	Diario
ESGV · VANGUARD WORLD FUND	0,01%	149 286 SH	19 de agosto de 2026	Diario
NEAR · iShares U.S. ETF Trust	0,01%	365 000 SH	9 de septiembre de 2026	Diario
DFUS · Dimensional ETF Trust	0,00%	5 257 NS	31 de julio de 2026	N-PORT
DFSU · Dimensional ETF Trust	0,00%	544 NS	31 de julio de 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	1 476 NS	31 de julio de 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	2 958 NS	31 de julio de 2026	N-PORT
IJH · iShares Trust	·	23 957 709 SH	11 de septiembre de 2026	Diario
IJJ · iShares Trust	·	3 487 441 SH	31 de agosto de 2026	Diario
XJH · iShares Trust	·	93 400 SH	8 de septiembre de 2026	Diario
ISCB · iShares Trust	·	29 420 SH	11 de septiembre de 2026	Diario
ISCV · iShares Trust	·	144 718 SH	11 de septiembre de 2026	Diario

AVTR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21

calificación · 25 analistas MANTENER

Objetivo mediano $14.20 -8,0%

3 12,0% Compra fuerte

5 20,0% Compra

16 64,0% Mantener

1 4,0% Venta

0 0,0% Venta fuerte

Precio objetivo a 12 meses

14 analistas · 2026-10-05

Objetivo medio $14.56 -5,6%

Ahora Precio Actual $15.43

Mín$12.00 Media$14.56 Máx$19.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker	Capitalización Bursátil	P/E	Ingresos interanuales	Margen Neto	ROE	Margen Bruto
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
TECH	$11.03B	60.9	-0.38%	15.0%	9.0%	65.8%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BIO	·	·	·	·	·	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

RBC Capital inicia cobertura de Avantor (AVTR) con calificación Sector Perform Yahoo Finance · 4 meses atrás

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

AVTR Avantor, Inc. Common Stock